Mike Labruto

Mike Labruto currently serves as the VP of Quality Assurance at GEMMA Biotherapeutics since October 2024. With extensive experience in quality assurance and compliance, Mike has held key positions, including Adjunct Professor of QA/RA at Temple University since January 2011, and Executive Director of Quality Assurance at the Gene Therapy Program at the University of Pennsylvania from January 2022 to October 2024. Previous roles at GSK included Quality Executive Director, Head of One Pharma QMS, and Director of Quality Process Improvement, where Mike focused on developing compliant quality systems for small molecules, biopharmaceuticals, and cell and gene therapies. Earlier in the career, Mike worked as Quality Control & Compliance Manager at Elan Pharmaceuticals and holds an MS in Pharmaceutical QA/RA from Temple University and a BS in Biology/Chemistry from Liberty University.